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In metazoan embryos, transcription is mostly silent for a few cell 27 
divisions, until release of a first major wave of embryonic transcripts by 28 
so-called zygotic genome activation (ZGA) 1. Maternally provided ZGA-29 
triggering factors have been identified in Drosophila melanogaster and 30 
Danio rerio 2,3, but their mammalian homologues are still undefined. 31 
Here, we reveal that the DUX family of transcription factors 4,5 is 32 
essential to this process in human and mouse. First, human DUX4 and 33 
murine Dux are both expressed prior to ZGA in their respective species. 34 
Second, both orthologues bind the promoters and activate the 35 
transcription of ZGA genes. Third, Dux knockout in mouse embryonic 36 
stem cells (mESCs) prevents their cycling through a 2-cell-like state. 37 
Finally, zygotic depletion of Dux leads to impaired early embryonic 38 
development and defective ZGA. We conclude that DUX proteins are key 39 
inducers of zygotic genome activation in placental mammals.  40 
Dux genes encode for double-homeodomain proteins and are conserved 41 
throughout placental mammals 4,5. Human DUX4, the intronless product of an 42 
ancestral DUXC, is nested within the D4Z4 macrosatellite repeat of 43 
chromosome 4 as an array of 10 to 100 units 6. DUX4, DUXC, and Dux genes 44 
from other placental mammals display the same repetitive structure, with 45 
DUX4 from primates and Afrotheria and DUXC from cow and other 46 
Laurasiatheria localizing at telomeric or pericentromeric regions, and murine 47 
Dux tandem repeats lying adjacent to a mouse-specific chromosomal fusion 48 
point that resembles a subtelomeric structure 4,5.  49 
Overexpression-inducing mutations in DUX4 are associated with facio-50 
scapulo-humeral dystrophy (FSHD), the third most common muscular 51 
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dystrophy 7,8, and forced DUX4 production in human primary myoblasts leads 52 
to upregulation of genes active during early embryonic development 9. Based 53 
on this premise, we analyzed publicly available RNA-seq datasets 54 
corresponding to this period, focusing on DUX4 and the 100 genes most 55 
upregulated in DUX4-overexpressing muscle cells (Figure 1A, Table S1) 10,11. 56 
DUX4 RNA was detected from oocyte to 4-cell (4C) stage, while transcripts 57 
from its putative targets emerged on average at 2-cell (2C) and peaked at 8-58 
cell (8C) stages, as previously defined for human ZGA 12. Transcripts 59 
upregulated in DUX4-overexpressing muscle cells 11 were also enriched at 8C 60 
stage (Supplementary Figure 1AB), and upon clustering genes according to 61 
their patterns of early embryonic expression (Figure 1B) we could delineate i) 62 
1517 genes, the transcripts of which were already detected in oocytes, 63 
plateaued up to 4C and abruptly dropped afterwards (maternal gene cluster); 64 
ii) 94 genes and 124 genes, the expression of which started at 2C, and 65 
peaked at 4C and 8C, respectively, before decreasing briskly, consistent with 66 
early ZGA genes (2-4C and 2-8C gene clusters); and iii) 1352 genes 67 
expressed only from 4C, peaking at 8C, and then decreasing progressively, 68 
as expected for late ZGA genes (4-8C gene cluster). Only the two early ZGA 69 
clusters (2-4C and 2-8C) were highly enriched for genes upregulated in 70 
DUX4-overexpressing myoblasts (Figure 1C, Supplementary Figure 1C). 71 
Chromatin cannot be reliably analyzed from the very low number of cells that 72 
make up an early embryo, but ChIP-seq data obtained in DUX4 73 
overexpressing human embryonic stem cells (hESCs) (Figure 2AB, 74 
Supplementary Figure 2) and myoblasts 9 (Supplementary Figure 3) revealed 75 
a marked enrichment of the transcription factor around the annotated 76 
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transcriptional start site (TSS) region of early ZGA genes (2-4C and 2-8C 77 
clusters), but not of zygotic (maternal) and late ZGA (4-8C) genes. 78 
Interestingly, several genes were not bound on their annotated TSS, but on 79 
neighboring sequences, and their transcription was found to start near this 80 
DUX4 binding site (Supplementary figure 4). It was previously demonstrated 81 
that DUX4 drives expression of many of its target genes from alternative 82 
promoters 11. Upon examining publicly available single-cell RNA sequencing 83 
data quantifying the far 5’-ends of transcripts (TFEs) in early human 84 
development 13, we correspondingly found that the TFE of 24 out of 31 early 85 
ZGA genes overlapped with DUX4 binding sites (Figure 2CD, Supplementary 86 
figure 3CD). DUX4 was also recruited to several groups of transposable 87 
elements (TEs), notably endogenous retroviruses such as HERVL, MER11B 88 
and C, the expression of which increased at ZGA (Supplementary figure 2BC). 89 
Furthermore, DUX4 overexpression in hESCs led to early ZGA genes 90 
induction, as previously observed in myoblasts (Figure 2E) 11. 91 
Dux and DUX4 have largely conserved amino acid sequences, in particular 92 
within the two DNA-binding homeodomains and the C-terminal region, 93 
previously described as responsible for recruiting p300/CBP (Supplementary 94 
Figure 5B) 14. The murine Dux tandem repeat encodes two main transcripts, 95 
full-length Dux (or Duxf3) and a variant named Gm4981 lacking the first 96 
homeodomain (Supplementary Fig. 5A). Both Dux and Gm4981 are 97 
expressed in mouse embryos prior to ZGA-defining genes and transposable 98 
elements (e.g. murine ERVL or MERVL) at the middle 2C stage, indicating 99 
that their products likely are functional homologues of DUX4 (Figure 3A) 15. 100 
To consolidate these results, we turned to mESCs, a small percentage of 101 
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which displays at any given time a 2C-like transcriptome in culture, with 102 
expression of ZGA genes notably from the MERVL promoter 16,17. Upon 103 
analyzing single-cell RNA-seq data from 2C-like mESCs 18, we confirmed that 104 
Dux transcripts were markedly enriched, as were early ZGA RNAs such as 105 
Zscan4, Zfp352 and Cml2  (Figure 3B and Supplementary Figure 6). We used 106 
CRISPR/Cas9-mediated genome editing to delete the Dux-containing 107 
macrosatellite repeat in mESCs expressing a GFP reporter under control of a 108 
MERVL promoter. This resulted in a complete absence of GFP+ 2C-like cells, 109 
and in the loss of a large fraction of 2C-like cell-specific transcripts (Figure 110 
3CD, Supplementary Figure 7). Overexpression of Dux but not DUX4 rescued 111 
the 2C-like state in the mESC KO clones (Figure 3EF, Supplementary Figure 112 
8 and 9), albeit not in all cells where Dux was produced (Figure 3G). 113 
Interestingly, both murine Dux and human DUX4 were able to induce the 114 
transcription of ZGA genes in the human 293T cell line (Supplementary Figure 115 
10). 116 
Upon depletion of the transcriptional repressor TRIM28 (tripartite motif-117 
containing protein 28; KAP1) from mESCs, expression of 2C-specific genes 118 
increased as previously observed 17, as did levels of Dux transcripts (Figure 119 
4A, Supplementary Figure 11BCD). Remarkably, this phenotype was 120 
completely abrogated in Dux-depleted mESCs (Figure 4BC, Supplementary 121 
Figure 9 and 11ABCD). Correspondingly, we found that TRIM28 associates 122 
with the 5’-end of the Dux gene and that tri-methylation of histone 3 lysine 9 123 
(H3K9me3), a canonical marker of TRIM28-mediated repression, was 124 
enriched on the Dux locus and lost upon knockdown of the heterochromatin 125 
inducer (Figure 4D, Supplementary Figure 11EF). 126 
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Finally, we addressed the role of Dux during murine early embryonic 127 
development. For this, we injected zygotes with plasmids encoding for the 128 
Cas9 nuclease and either the two guide RNAs (sgRNAs) used to generate 129 
Dux KO mESCs or a non-targeting sgRNA control. We then determined the 130 
RNA profile of 2C embryos around 7 hours after the first cell division or 131 
monitored their ex vivo development into blastocysts over 4 days (Figure 5A). 132 
We found that Dux–depleted embryos presented a major differentiation defect, 133 
most failing to reach the morula/blastocyst stage, and did not exhibit 134 
transcriptional changes typical of ZGA, such as induction of MERVL, Zscan4 135 
and several other tested early ZGA genes, and drop in Mpo maternal 136 
transcript (Figure 5BC, Supplementary Figure 12). 137 
In sum, our data reveal DUX genes as key regulators of early embryonic 138 
development. The demonstrated ability of DUX4 to recruit the p300/CBP 139 
complex and to induce local chromatin relaxation 14 as well as the mechanism 140 
of action of Zelda, a master inducer of ZGA in Drosophila 19,20, suggest that 141 
DUX proteins could act as pioneer factors for transcriptional activation, by 142 
opening chromatin around the TSS of early ZGA genes to facilitate access for 143 
other transcription factors. Still, the genomic recruitment of pioneer factors 144 
such as OCT4, NANOG and KLF4 can be hampered if heterochromatin marks 145 
are overly abundant at their target loci 21. Many murine ZGA genes are 146 
expressed from the LTR of endogenous retroviruses, which in mESC cells are 147 
typically enriched in repressive marks 17. It could be that, at any given time, 148 
these marks are relieved in only a small percentage of mESC in culture. What 149 
drives this fluctuation remains to be determined. As well, what controls 150 
expression of DUX genes themselves is yet to be defined, although the 151 
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conserved genomic localization of all placental mammal DUX orthologs close 152 
to telomeric and subcentromeric regions suggests that this genomic context, 153 
characterized by high levels of repression, might be of primary relevance 4,5,22. 154 
DUX genes seem indeed to become expressed only during events associated 155 
with major chromatin relaxation, for instance in early embryos and upon loss 156 
of repression of the D4Z4 macrosatellite repeat in myoblasts of FSHD patients 157 
23,24. Our data indicate that TRIM28 plays a major role in murine Dux 158 
repression, but the only mild increase in cells entering the 2C state when it is 159 
depleted (around 5% of mESCs) and the demonstrated ability of several other 160 
transcriptional modulators (e.g. SETDB1, EHMT2, HP1, CHAF1A/B, RYBP, 161 
KDM1A) to prevent cycling of mESCs through this state indicate that control 162 
of the Dux macrosatellite repeat is most likely multifactorial 16,25-29. Broad de-163 
repression of the human and murine DUX-containing repeats could similarly 164 
occur right after fertilization in either species. Future investigations of the 165 
chromatin state of these loci in early embryos will shed light on the epigenetic 166 
changes responsible for this process and on the nature of their molecular 167 
mediators.   168 
 169 
Materials and methods 170 
 171 
Cell lines and tissue culture 172 
mESC WT and KO for Trim28 30, and E14 mESCs containing the MERVL 173 
regulatory sequence driving expression of a 3XturboGFP-PEST 16 were 174 
cultured in feeder-free conditions on 0.1% gelatin-coated tissue culture plates 175 
in 2i medium, a N2B27 base medium supplemented with the MEK inhibitor, 176 
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PD0325901 (1 μM), the GSK3β inhibitor CHIR99021 (3 μM) and LIF. E14 177 
mESCs express the main markers of pluripotency (RNA-seq). H1 ESCs 178 
(WA01, WiCell) were maintained in mTesRI (StemCell Technologies) on hES-179 
qualified Matrigel (BD Biosciences). 293T cells were maintained in DMEM 180 
supplemented with 10% FCS. All cells were regularly checked for the absence 181 
of mycoplasma contamination. 182 
 183 
Plasmids and lentiviral vectors 184 
The MT2/gag sequence was amplified from the pGL3 plasmid 29, and the 185 
human PGK promoter from pRRLSIN.cPPT.R1R2.PGK-GFP.WPRE 30, to be 186 
cloned upstream of luciferase in pGL4.20. Table S2 shows the primers used 187 
to obtain truncations of the MT2/gag sequence. Single guide RNAs (sgRNAs) 188 
targeting sequences flanking the 5’ and 3’ of the Dux-containing 189 
macrosatellite repeat were cloned into px459 (version 2) using a standard 190 
protocol 31. Table S2 shows the primers used to clone the sgRNAs. The 191 
pLKO.1-puromycin shRNA vector was used for the Trim28 knock-down 30. 192 
The pLKO.1 vector was further modified to express blasticidin-S-deaminase 193 
drug resistance cassette in place of the puromycin N-acetyltransferase. The 194 
resulting pLKO.1-blasticidin backbone was used to clone shRNAs against the 195 
murine Dux transcript. The sequence of the primers used to clone the Dux 196 
shRNA is shown in Table S2. The Gm4981 cDNA was cloned from the 197 
genome of E13 mESCs while codon-optimized hDUX4 and mDux were 198 
synthesized (Invitrogen). Gm4981, DUX4, Dux and LacZ cDNAs were cloned 199 
in the pAIB HIV-1-based transfer vector encoding also for blasticidin 200 
resistance using the In-Fusion® HD Cloning Kit (Clontech) 32. pMD2-G 201 
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encodes the vesicular stomatitis virus G protein (VSV-G). The minimal HIV-1 202 
packaging plasmid 8.9NdSB carrying a double mutation in the capsid protein 203 
(P90A/A92E) was used to achieve higher transduction of the lowly permissive 204 
mESCs 33. 205 
 206 
Production of lentiviral vectors, transduction and transfection of mammalian 207 
cells 208 
Lentiviral vectors were produced by transfection of 293T cells using 209 
Polyethylenimine (PEI) (Sigma, Inc) 33. To generate stable KDs, mESCs were 210 
transduced with empty pLKO.1 vector or vectors containing the shRNA 211 
targeting Kap1 or Dux transcripts 30. Cells were selected with 1 μg⁄ml 212 
puromycin or 3 μg⁄ml blasticidin starting one day after transduction. hESCs 213 
expressing LacZ and DUX4 were generated by transfecting the corresponding 214 
AIB plasmids with TransIT®-LT1 Transfection Reagent (Mirus Bio LLC), while 215 
nucleofection (Amaxa™ P3 Primary Cell 4D-Nucleofector™ X Kit) was used 216 
to engineer mESC expressing LacZ, DUX4, Dux and Gm4981.   217 
 218 
Creation of Dux KO mESC lines 219 
E14 mESCs containing the MERVL regulatory sequence driving expression of 220 
a 3XturboGFP-PEST were co-transfected with px459 plasmids encoding for 221 
Cas9, the appropriate sgRNAs and puromycin resistance cassette by 222 
nucleofection (Amaxa™ P3 Primary Cell 4D-Nucleofector™ X Kit). 24 hours 223 
later, the cells were selected for 48 hours with 1 μg⁄ml puromycin, single-cell 224 
cloned by serial dilution, expanded and their DNA was extracted to detect the 225 
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presence of WT and/or KO alleles. Three WT and three homozygous Dux KO 226 
clones were selected and used in this study. 227 
 228 
Luciferase assay 229 
293T or E14 mESCs were cotransfected with the various pGL4.20 derivatives, 230 
the renilla plasmid and the pAIB transfer vector encoding either for LacZ, Dux, 231 
Gm4981 or DUX4 using Lipofectamine 3000 (Invitrogen). Luciferase activity 232 
was quantified 24h after transfection. Firefly luciferase activity was normalized 233 
to the activity of Renilla luciferase. Light emission was measured on a 234 
luminescence plate reader. 235 
 236 
Immunofluorescence assay  237 
mESC clones expressing an HA-tagged Dux protein were fixed for 20 min 238 
with 4% paraformaldhyde, permeabilized for 5 min with 0.1% Triton-X 100, 239 
and blocked for 30 min with 1% BSA in PBS. Cells were then incubated for 1 240 
hour with anti-HA.11 (Covance) or anti-NANOG (Active Motif) or anti-SOX2 241 
(Active Motif) antibodies diluted in PBS with 1% BSA. After 3 washes, the 242 
cells were incubated with anti-mouse (HA) or anti-rabbit (NANOG, SOX2) 243 
Alexa Fluor 647-conjugated secondary antibodies for 1 hour and washed 244 
again three times. Every step until this point, was carried with cells in 245 
suspension. Pelleted cells were then resuspended in VECTASHIELD® 246 
Mounting Medium with DAPI (Vector Laboratories) and mounted on the 247 
coverslip. The slides were viewed with a Zeiss LSM700 confocal microscope.  248 
 249 
Fluorescence-activated cell sorting (FACS) 250 
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FACS analysis was performed with a BD FACScan system. Trim28 knock-251 
down mESCs containing the MT2/gag-GFP reporter were subjected to FACS 252 
sorting with AriaII (BD Biosciences). 253 
 254 
Standard PCR, RT-PCR and RNA sequencing 255 
For the genotyping of Dux WT and KO alleles, genomic DNA was extracted 256 
with DNeasy Blood & Tissue Kits (QIAGEN) and the specific PCR products 257 
were amplified using PCR Master Mix 2X (Thermo Scientific) combined with 258 
the appropriate primers (design in Supplementary Figure 6A; primer 259 
sequences in Table S2). 260 
Total RNA from cell lines was isolated using the High Pure RNA Isolation Kit 261 
(Roche). cDNA was prepared with SuperScript II reverse transcriptase 262 
(Invitrogen). Ambion Single Cell-to-CT kit (Thermo Fisher) was used for RNA 263 
extraction, cDNA conversion and mRNA pre-amplification of 2C stage 264 
embryos. Primers listed in Supplementary Table S2 were used for SYBR 265 
green qPCR (Applied Biosystems). Library preparation and 150-base-pair 266 
paired-end RNA-seq were performed using standard Illumina procedures for 267 
the NextSeq 500 platform (GSE94325). 268 
 269 
ChIP and ChIP sequencing 270 
ChIP and library preparation were performed as described previously 30. 271 
DUX4-HA ChIP was done using the anti-HA.11 (Covance) antibody. 272 
Sequencing of Trim28 and H3K9me3 ChIP was performed with Illumina 273 
HiSeq 2500 in 100-bp reads run. Sequencing of DUX4 was performed with 274 
Illumina NextSeq 500 in 75-bp paired-end reads run. 275 
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 276 
RNA-seq datasets preprocessing 277 
Single-cell RNA-Seq of human and mouse early embryo development 278 
(GSE36552 and GSE45719 respectively), single-cell RNA-Seq of 2C-like cells 279 
(E-MTAB-5058), DUX4 overexpression in human myoblasts (GSE45883), and 280 
KAP1 KO (GSE74278) datasets were downloaded from different repositories 281 
(GEO, and ArrayExpress) 34,35. Reads were mapped to the human genome 282 
(hg19) or mouse genome (mm9) using TopHat (v2.0.11) 36 in sensitive mode 283 
(the exact parameters are: tophat -g 1 --no-novel-juncs --no-novel-indels -G 284 
$gtf --transcriptome-index $ transcriptome --b2-sensitive -o $localdir $index 285 
$reads1 $reads2). Gene counts were generated using HTSeq-count. 286 
Normalization for sequencing depth and differential gene expression analysis 287 
was performed using Voom 37 as it has been implemented in the limma 288 
package of Bioconductor 38. TEs overlapping exons were removed from the 289 
analysis. Counts per TE integrant (genomic loci) were generated using the 290 
multiBamCov tool from the bedtools software 39. Normalisation for sequencing 291 
depth was performed using Voom, with total number of reads on genes as 292 
size factor. To compute total number of reads per TE family, counts on all 293 
integrants of each family were added up. 294 
 295 
Analysis of single cell expression data from human and mouse embryonic 296 
stages 297 
For every embryonic stage we performed a statistical test to find the genes 298 
that had a different expression level compared to the other stages 10, using a 299 
moderated F-test (comparing the interest group against every other) as 300 
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implemented in the limma package of Bioconductor. Genes were selected as 301 
expressed in a specific stage if having a significant p-value (<0.05 after 302 
adjusting for multiple testing with the Benjamini and Hochberg method) and 303 
an average fold change respective to the other embryonic stages bigger than 304 
10. We additionally removed all genes exhibiting a 1.1-fold higher expression 305 
in any of the embryonic stages compared to the stage analyzed (Suppl. 306 
Figure 1A). Note that with this approach a gene can be marked as expressed 307 
in more than one stage. Codes are available on demand. 308 
 309 
Correspondence between DUX4 overexpression and single cell expression 310 
data from human embryonic stages 311 
For every stage, we classified the genes in 4 patterns of expression by 312 
performing a hierarchical clustering (with Pearson correlation as distance and 313 
complete agglomeration method). Figure 1B shows the 2 most relevant 314 
patterns derived from the 4C and 8C stages. 315 
Expression of the genes identified with this method was then compared 316 
between DUX4- and GFP-overexpressing human myoblast cells. For a gene 317 
to be considered differentially expressed, a p-value (after multiple testing 318 
correction with the Benjamini and Hochberg method) lower than 0.05 and a 319 
fold change bigger than 2 were imposed. A moderated t-test was used for the 320 
statistical test, as implemented in the limma package of Bioconductor. 321 
 322 
ChIP-seq data processing 323 
ChIP-seq dataset of DUX4 overexpressed in human myoblasts (GSE94325) 324 
was downloaded from GEO. Reads were mapped to the human genome 325 
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assembly hg19 using Bowtie2 using the sensitive-local mode 40. SICER was 326 
used to call histone mark peaks 41. For the ones that are not histone marks, 327 
we used MACS (with default parameters) when the data was single-end and 328 
MACS2 (the exact parameters are: macs2 callpeak -t $chipbam -c $tibam -f 329 
BAM -g $org -n $name -B -q 0.01 --format BAMPE) when the data was 330 
paired-end 42. Both, SICER peaks with an FDR above 0.05 and MACS peaks 331 
with a score lower than 50 were discarded. RSAT was used for motif 332 
discovery and to compute motif abundance 43. To compute the percentage of 333 
bound TE integrants in each family, we used bedtools suite. 334 
 335 
Coverage plots 336 
ChIP-seq signals on features of interest were extracted from the bigWigs 337 
beforehand normalized for sequencing depth (reads per hundred millions). 338 
Each signal was then smoothed using a running average of window 75bp for 339 
DUX4, 250bp for Trim28, and 500bp for H3K9me3. Finally, the mean and 340 
standard error of the mean of the signals were computed and plotted for each 341 
set of features of interest. Scripts are available on demand. 342 
 343 
Pronuclear injection of mouse embryos 344 
Pronuclear injection was performed according to the standard protocol of the 345 
Transgenic Core Facility of EPFL. In summary, B6D2F1 mice were used as 346 
egg donors (5 weeks old). Mice were injected with PMSG (10 IU), and HCG 347 
(10 IU) 48 hours after. After mating females with B6D2F1 males, zygotes 348 
were collected and kept in KSOM medium pre-gassed in 5% CO2 at 37 °C. 349 
Embryos were then transferred to M2 medium and microinjected with 10 350 
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ng/μg of either a px459 plasmid containing a non-targeting sgRNA or a mix of 351 
the two plasmids used to obtain the KO in mESCs, in injection buffer (10mM 352 
Tris HCl pH7.5, 0.1mM EDTA pH8, 100mM NaCl). After microinjection, 353 
embryos were cultured in KSOM medium at 37 °C in 5% CO2 for 4 days. In 354 
each of three independent experiments, 5 embryos per condition were 355 
collected around 7 hours after first cell division (2C formation) for qPCR 356 
analysis, and differentiation of the remaining embryos was followed. At day 4, 357 
all the fertilized embryos (between 16 to 23 per condition) were classified for 358 
their developmental state. Randomization and blind outcome assessment 359 
were not applied. All animal experiments were approved by the local 360 
veterinary office and carried out in accordance with the EU Directive (2010/63/ 361 
EU) for the care and use of laboratory animals. 362 
 363 
Sample sizes and statistical tests 364 
We used non-parametric statistical tests (2-sided Wilcoxon test), when we 365 
had enough sample size (low-cell number qPCR). Otherwise we used a 2-366 
sided unpaired t-test (standard qPCR and FACS). Fisher’s exact test was 367 
used to test for differences in proportions in contingency tables. 368 
 369 
Data availability 370 
RNA-seq and ChIP-seq data generated in this study have been deposited in 371 
the NCBI Gene Expression Omnibus (GEO) under accession number 372 
GSE94325. 373 
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Figure Legends 529 
Figure 1. DUX4 promotes transcription of genes expressed during early 530 
ZGA 531 
(A) Comparative expression during early human embryonic development of 532 
DUX4 (red) and the top 100 genes upregulated upon DUX4 overexpression in 533 
human primary myoblasts (blue, full line average, dashed lines 95% 534 
confidence interval around the mean). Oo, oocyte; Zy, zygote; 2C, 4C, 8C, 535 
corresponding n-cell stage; Mo, morula; Bl, blastocyst. (B) Cluster of genes 536 
differentially expressed during early embryonic development were selected 537 
from the previously identified subsets of genes (Supplementary Figure 1A) 538 
based on high expression at 4C (upper panels) and 8C (lower panels). Blue 539 
and dotted line delineate mean and 95% confidence, respectively. (C) 540 
Expression of genes from each cluster illustrated in (B) when DUX4 is 541 
ectopically expressed in human primary myoblasts. Lower parts of the panels 542 
depict the fold change expression of genes within these clusters, all randomly 543 
distributed along the y-axes, with kernel density plotted in the upper part.  544 
 545 
Figure 2. DUX4 binds TSSs of genes expressed during early ZGA and 546 
activates their expression in hESCs. 547 
(A) Average coverage normalized for sequencing depth of ChIP-seq signal of 548 
DUX4 (blue) when overexpressed in hESCs in a window of 5 kb from the 549 
annotated TSS of genes belonging to the 2-4C and 2-8C clusters from Figure 550 
1B. Total input is represented in gray (line, average; shade, standard error of 551 
the mean). B) Fraction of genes belonging to each cluster from Figure 1B with 552 
a DUX4 peak within 5 kb of their annotated TSS. Fisher’s exact test was 553 
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performed to compare maternal vs. 2-4C and 2-8C (p= 3.54e-61 and p= 2.23e-554 
13 respectively) (C) Average coverage of ChIP-seq signal of DUX4 (blue) 555 
when overexpressed in hESCs within 5 kb of TFE of transcripts specifically 556 
upregulated at oocyte-to-4C and 4C-to-8C transitions. Total input is 557 
represented in gray (line, average; shade, standard error of the mean). (D) 558 
Fraction of TFE from oocyte-to-4C (n=32) and 4C-to-8C (n=128) transitions 559 
that have a DUX4 peak overlapping with their 5' end. Fisher’s exact test was 560 
performed to compare 4C-to-8C vs. oocyte-to-4C TFEs (p= 4.48e-17). (E) 561 
Comparative expression in hESCs of three genes activated at ZGA (ZSCAN4, 562 
MBD3L2 and DUXA) and two control housekeeping genes (ACTB and TBP) 563 
24 hours after transfection with plasmids expressing LacZ (green squares) or 564 
DUX4 (blue circles). Expression was normalized to ACTB. Horizontal lines 565 
represent the mean. *** p ≤ 0.001,  unpaired t-test. 566 
 567 
Figure 3. Dux is necessary for formation of 2C-like mESCs. 568 
(A) Comparative expression of the two alternative transcripts of Dux, Dux 569 
(pink) and Gm4981 (orange), with genes (blue) and transposable elements 570 
(MERVL; green) specifically expressed during murine ZGA. Full lines 571 
represent the average and dashed lines the 95% confidence interval around 572 
the mean (B) Single-cell RNA-sequencing comparison between mESCs 573 
sorted for expression of both tomato and GFP reporters driven by MERVL 574 
and Zscan4 promoters, respectively (revelators of 2C-like cells), and the 575 
double negative population. Average gene expression was quantified and fold 576 
change between positive and negative cells was plotted. Dots are randomly 577 
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distributed along the y-axes. The upper plot represents the kernel density 578 
estimate of middle-2C stage (blue line) and the rest of the genes (gray line).  579 
The Dux macrosatellite repeat was deleted in mESCs carrying a MERVL-GFP 580 
reporter by CRISPR/Cas9-mediated excision. (C) Fraction of GFP+ cells in 581 
WT or Dux-deleted cells. (D) RNA sequencing analysis of WT and Dux KO 582 
mESC clones. The dot plot displays the average gene expression of three 583 
independent clones from each cell type. (E) GFP expression in Dux KO (blue 584 
circles) and WT (green squares) mESC clones carrying an integrated 585 
MERVL-GFP reporter, and transiently expressing LacZ, DUX4, Dux or 586 
Gm4981 transgenes. (F) RNA sequencing analysis of Dux KO mESC clones 587 
transiently expressing Dux or control. The dot plot displays the average gene 588 
expression of two independent clones from each cell type. (G) Dux KO 589 
mESCs carrying an integrated MERVL-GFP reporter and transiently 590 
expressing a HA-tagged form of Dux were stained for HA and 591 
immunofluorescence was detected by confocal microscopy. DAPI, blue; GFP, 592 
green; HA, red. Horizontal bars in (C) and (E) represent the mean. *** p ≤ 593 
0.001, unpaired t-test. 594 
 595 
Figure 4. TRIM28 regulates formation of 2C-like mESCs by repressing 596 
Dux expression 597 
(A) RNA sequencing analysis of WT and Trim28 KO mESCs. Average gene 598 
expression was quantified and fold change between KO and WT cells plotted. 599 
Dots are randomly distributed along the y-axes. The upper plot represents the 600 
kernel density estimate of genes specifically expressed in 2C-like mESCs 601 
(green line) and the rest of the genes (gray line). (B) WT (blue circles) and 602 
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Dux KO (green squares) mESC clones carrying an integrated MERVL-GFP 603 
reporter were transduced with lentiviral vectors encoding for shRNAs targeting 604 
Trim28 or a control. 4 days later GFP expression was quantified. Horizontal 605 
lines represent the mean. *** p ≤ 0.001, unpaired t-test. (C) RNA sequencing 606 
of Trim28-depleted or control Dux KO mESC clones. The dot plot represents 607 
the average gene expression of three independent KO clones transduced with 608 
lentiviral vectors encoding for a control or a Trim28-specific shRNA. (D) 609 
Average coverage of ChIP-seq signal of Trim28 (top plot; blue lines; two 610 
replicates) and H3K9me3 (bottom plot; two replicates) in control (red lines) 611 
and Trim28 KD mESCs (green line) around the Dux gene. Total input is 612 
represented in gray. ChIP-seq reads were mapped on the genome, before 613 
focusing the analysis on a 500bp window around the main Dux gene. 614 
H3K9me3 peaks over the Dux macrosatellite repeat were only called in the 615 
control KD mESCs (Sicer; false discovery rate 0.05) 616 
  617 
Figure 5. Dux is necessary for mouse early embryonic development 618 
(A) Schematic of the Dux loss-of-function experiment in mouse pre-619 
implantation embryos. Zygotes were first injected in the pronucleus with 620 
plasmids encoding for the Cas9 nuclease and sgRNAs targeting the flanking 621 
region of the Dux macrosatellite repeat or a non-targeting sgRNA, then were 622 
either (B) monitored for their ability to differentiate ex vivo or (C) collected at 623 
2C-stage for mRNA quantification. (B) Average percent of embryos reaching 624 
the morula/blastocyst stages (white) or failing to differentiate (delayed/dead 625 
embryos, black; defective morula/blastocyst, grey) 4 days after pronuclear 626 
injection. The plot represents an average from 3 independent experiments 627 
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with 16 to 23 embryos for each condition. Fisher’s exact test was performed to 628 
compare the embryonic stage of control against Dux KO (p= 1.54e-10) (C) 629 
Comparative expression of Dux, early ZGA genes (Zscan4, Sp110, 630 
B020004J07Rik, Dub1, Tdpoz4, Eif1a, Tcstv3, Cml2), 2C-restricted TE 631 
(MERVL, the LTR and int regions of which are detected with MT2_mm and 632 
MERVL-int primers, respectively), a gene (Mpo), the expression of which 633 
decreases at ZGA, 2 genes (Actb, Zbed3) stably expressed during pre-634 
implantation embryonic development and a control TE (IAPEz) in 15 2C stage 635 
embryos (5 from each of 3 independent experiments) 15-24 hours after 636 
pronuclear injection with plasmids expressing Cas9 and control or Dux-637 
specific sgRNAs. Boxes depict the 25 and 75 percentiles, line in the boxes 638 
represents the median. Expression was normalized to Actb. * p ≤ 0.05 ** p ≤ 639 
0.01, *** p ≤ 0.001, Wilcoxon test. 640 
